Skip to main content

Find Clinical Trials

Home
Conditions
TDP-43 Proteinopathies

Clinical trial condition

TDP-43 Proteinopathies

Explore clinical trials studying TDP-43 Proteinopathies. Study availability and eligibility vary by location and protocol.

871 public trials 211 recruiting studies

Refine in advanced search Browse all conditions

TDP-43 Proteinopathies trial results

Completed

Safety and Tolerability of Anakinra in Combination With Riluzol in Amyotrophic Lateral Sclerosis

NCT01277315

Conditions: Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, +10 more
Locations: Charité University Hospital Berlin, Germany

View Trial Details

Completed

Group-Based Telehealth Music Therapy Intervention for Patients With Dementia: A Pilot Study

NCT05508646

Conditions: Alzheimer Disease, Basal Ganglia Diseases, Behavior, +19 more
Locations: Maya Lichtenstein Wilkes-Barre, Pennsylvania, United States

View Trial Details

Completed

Enoxacin for Amyotrophic Lateral Sclerosis (ALS)

NCT04840823

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations: Montreal Neurological Institute-Hospital Montreal, Quebec, Canada

View Trial Details

Completed

Study of ALS Reversals 2: Genetic Analyses

NCT03464903

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +10 more
Locations: Duke ALS Clinic / DUSOM Dept of Neurology / DUHS Durham, North Carolina, United States

View Trial Details

Completed

HERV-K Suppression Using Antiretroviral Therapy in Volunteers With Amyotrophic Lateral Sclerosis (ALS)

NCT02437110

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Infections, +10 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Completed

Study of Structural and Functional Brain Connectivity Changes in ALS (CoALS-II)

NCT05404867

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations: Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States

View Trial Details

Completed

Real World Testing of a Brain-Computer Interface

NCT04026581

Conditions: Amyotrophic Lateral Sclerosis, Brain Damage, Chronic, Brain Diseases, +36 more
Locations: AAC Institute Clinic (ICAN Talk Clinic) Carnegie, Pennsylvania, United States

University of Pittsburgh, AAC Performance and Testing Laboratory Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

Exploring Accessible Beauty for Individuals With Upper Extremity Deficits

NCT05945784

Conditions: Amyotrophic Lateral Sclerosis, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +81 more
Locations: Casa Colina Hospital and Centers for Healthcare Pomona, California, United States

View Trial Details

Completed

Frequency of SOD1 and C9orf72 Gene Mutations in French ALS

NCT04819555

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations: CHU Angers Angers, France

CHU Bordeaux Bordeaux, France

CHU de Brest Brest, France

CHU Lyon Bron, France

View all 20 locations

View Trial Details

Completed

Inhibition of Rho Kinase (ROCK) With Fasudil as Disease-modifying Treatment for ALS

NCT03792490

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations: Centre Hospitalier Universitaire Marseille Marseille, France

Centre Hospitalier Universitaire Montpellier Montpellier, France

Centre Hospitalier Universitaire Nice Nice, France

Centre Hospitalier Universitaire Tours Tours, France

View all 15 locations

View Trial Details